FDA Investigator Renee L Rice, PhD

Renee L Rice, PhD has conducted inspections on 12 sites in 1 countries as of 11 Jun 2001. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:

Last Inspection Date:

11 Jun 2001

Investigator Role:

FDA Investigator

Redica ID:

100002161

Countries of Inspections:

United States of America

FDA Investigators that have inspected at least one site in common with Renee L Rice, PhD:

Andrea F White, Anh M Lac, Anita Narula, PhD, Ann Raju Daniel, Anthony E Keller, RPh, Art O Czabaniuk, Aurora Miha Trifanov, Azza Talaat, Bleta Vuniqi, Carmen M Faraianu, Caroline H Le, Catherine V Quinlan, Charles A Snipes, PhD, Courtney E Hillier, Crystal L Parks, Crystal M Young Lewis, Daniel J Brown, Daniel J Roberts, Daniel W Stoll, David L Wilson, Emilie E Kahn, Emily J Orban, Geneve M Parks, Hokenson, Ita Yuen, PhD, Jacob G Lutz, Jeffrey D Meng, Jennifer A Kemp, John N Woodall, Justin M Tomczak, Kathryn E Ogger, Kathryn G Brown, Kip R Meleski, L'oreal D Fowlkes, L'oreal F Walker, Larry K Austin, Laureen F Kononen, Leslie A Paul, Linda S Jozefiak, Lisa P Oakes, LTJG Aaron B Otis, Margaret N Persich, Martin R Vowell, Matthew J Gretkierewicz, Miah I Schneider, Michele L Forster, PhD, Mikhail V Ovanesov, PhD, Monica L Hughes, Natalie A Mickelsen, DVM, Neali H Lucas, Nicholas E Boyd, Owens, Patsy J Domingo, Phenicia T Petty, Rasha Bamieh, Rebecca A Olotu, Rebecca E Dombrowski, Regina T Brown, Robert M Barbosa, Robert P Whisenant, Roger A Hartman, Rohn R Robertson, Ryan J Benedict, Sarah M Meng, Sarah M Napier, Stuart W Russell, Susan M North, Tina M Pawlowski, Tracey L Siebesma, Tracey L Taylor, Twana R Chandler, Vanessa J Colburn, Victoria A Murray, William V Millar

Renee L Rice, PhD's Documents

Publish Date	Document Type	Title
October, 2000	FDA 483	Biological Research Solutions, Inc. - Form 483, 2000-10-10
April, 2001	FDA 483 Response	Sun Pharmaceutical Industries, Inc. - Form 483R, 2001-05-25
December, 2000	FDA 483 Response	Genesis Pharmaceutical, Inc. - Form 483R, 2001-01-31
December, 2000	EIR	Genesis Pharmaceutical, Inc. - EIR, 2000-12-11
June, 2001	EIR	Pfizer, Inc. - EIR, 2001-06-21
April, 2001	EIR	Sun Pharmaceutical Industries, Inc. - EIR, 2001-04-25
April, 2001	FDA 483	Sun Pharmaceutical Industries, Inc. - Form 483, 2001-04-25
December, 2000	FDA 483	Genesis Pharmaceutical, Inc. - Form 483, 2000-12-11

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

Total inspections conducted
483 rate
OAI rate
Warning Letter rate
Inspections by Industry, Scope, and Inspection Reason
And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

Talk to sales to access our investigator profiles

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

Pre-Approval Inspection (PAI) trends
The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
Latest 483s: see what the trends are across all FDA Investigators
CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

Full inspection histories for your vendors down to the specific site level
All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more